| Peyronie's disease: Evolving surgical management and the role of phosphodiesterase 5 inhibitors - Abstract |
|
|
|
|
|
| Tuesday, 29 September 2009 | ||
|
Division of Urology, Department of Surgery, University of Western Ontario, London, ON This email address is being protected from spam bots, you need Javascript enabled to view it
Peyronie's disease (PD) is a fibrotic disorder of the tunica albuginea of the penis. It is characterized by different degrees of penile curvature and sexual dysfunction. Several medical treatments have been employed to manage the disorder, with variable success rates. Surgical therapy is reserved for patients with severe penile deformity that fails to improve with medical treatment and impedes coital function. The advantages and disadvantages of various surgical approaches have long been debated. Herein, we describe the evolving surgical techniques for PD using knowledge obtained from the contemporary literature. In addition, we discuss the emerging data regarding the role of phosphodiesterase 5 inhibitors in the management of PD.
Written by:
Reference:
PubMed Abstract
UroToday.com Peyronie's Disease Section
Please log-in or register in order to submit comments. Powered by AkoComment! |
||
| < Prev | Next > |
|---|
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |










